Form 4: Kestra Medical Technologies Executive Sells Shares
Insider Transaction (Form 4)
Timothy P. Moran, Chief Business Officer of Kestra Medical Technologies, Ltd., sold 15,256 shares of common stock on July 30, 2026.
Summary
- Open-market sale: disposed of 4,117 Common Shares at $22.77 ($93,758) on July 30, 2026; holds 77,484 after (Direct).
- Open-market sale: disposed of 8,759 Common Shares at $22.61 ($198,001) on July 31, 2026; holds 68,725 after (Direct).
- Open-market sale: disposed of 2,380 Common Shares at $23.76 ($56,551) on August 3, 2026; holds 66,345 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $348,311 of stock on the open market.
Insider Transactions
Timothy P. Moran — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-30 | Open-market sale | Common Shares | 4,117 | $23 | $93.8K | 77,484 |
| 2026-07-31 | Open-market sale | Common Shares | 8,759 | $23 | $198.0K | 68,725 |
| 2026-08-03 | Open-market sale | Common Shares | 2,380 | $24 | $56.6K | 66,345 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-30 | Open-market sale (4,117 shares) |
| 2026-07-31 | Open-market sale (8,759 shares) |
| 2026-08-03 | Open-market sale (2,380 shares) |
Keywords
insider transaction, Form 4, KMTS, KESTRA MEDICAL TECHNOLOGIES, LTD., bearish, Timothy P. Moran
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.